Design, Synthesis and Biological Evaluation of New 5-(2-Nitrophenyl)-1-aryl-1H-pyrazoles as Topoisomerase Inhibitors

dc.contributor.authorKaur, Manpreet
dc.contributor.authorMehta, Vikrant
dc.contributor.authorArora, Sahil
dc.contributor.authorMunshi, Anjana
dc.contributor.authorSingh, Sandeep
dc.contributor.authorKumar, Raj
dc.date.accessioned2024-01-21T10:54:01Z
dc.date.accessioned2024-08-14T07:40:47Z
dc.date.available2024-01-21T10:54:01Z
dc.date.available2024-08-14T07:40:47Z
dc.date.issued2021-07-09T00:00:00
dc.description.abstract5-(2-Nitrophenyl)-1-aryl-1H-pyrazoles are designed as topoisomerase (Topo) inhibitors, synthesised and assessed for their anticancer properties against breast (MDA-MB-231 and MCF7), lung (A549), and colorectal (HCT116) cancer cell lines. All the compounds induced significant cytotoxicity at low micromolar concentration. The compound 5e exerted potential anticancer effects on breast cancer cell lines at a low micromolar level (IC50<2 ?M), and showed negligible toxicity towards normal cells. Compound 5 e reduced reactive oxygen species (ROS) level in breast cancer cells, altered mitochondrial membrane potential and induced the cell cycle arrest at the G2/M phase. This was accompanied by downregulation of oncogenic p-Akt and upregulation of p-PTEN along with modulation of apoptotic markers suggesting multiple mechanisms to reduce cancer cell viability. Finally, the topoisomerase inhibition assay revealed the inhibitory activity of 5 e against Topo I and Topo II. � 2021 Wiley-VCH GmbH.en_US
dc.identifier.doi10.1002/slct.202101459
dc.identifier.issn23656549
dc.identifier.urihttp://10.2.3.109/handle/32116/4186
dc.identifier.urlhttps://chemistry-europe.onlinelibrary.wiley.com/doi/10.1002/slct.202101459
dc.language.isoen_USen_US
dc.publisherJohn Wiley and Sons Incen_US
dc.subjectCanceren_US
dc.subjectCell cycleen_US
dc.subjectN-heterocyclesen_US
dc.subjectPyrazolesen_US
dc.subjectTopoisomeraseen_US
dc.titleDesign, Synthesis and Biological Evaluation of New 5-(2-Nitrophenyl)-1-aryl-1H-pyrazoles as Topoisomerase Inhibitorsen_US
dc.title.journalChemistrySelecten_US
dc.typeArticleen_US
dc.type.accesstypeClosed Accessen_US

Files